Support PenkeCollegium Pharmaceutical Inc - Trending symbols
Latest News of Collegium Pharmaceutical Inc
| Date | Title | Read |
|---|---|---|
| 2025-11-06 18:48 | Collegium Pharmaceutical Shares Rise 12% After Q3 Results And Guidance Raise | Read |
| 2025-10-30 22:15 | Thérapeutique Knight annonce le lancement de JORNAY PM(MC) au Canada | Read |
| 2025-10-30 22:15 | Knight Therapeutics Announces Launch of JORNAY PM™ in Canada | Read |
| 2025-10-10 21:51 | UnitedHealth, Brookdale, Collegium Pharmaceutical, QuidelOrtho, and Biogen Shares Are Falling, What You Need To Know | Read |
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Overbought | Overbought RSI (Relative Strength Index) | 2025-11-07 |
Trends
| 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation and Amortization | 35,463 | -29 | 35,434 | 33 | 35,467 | 6,280 | 41,747 | -43,559 | -1,812 | |
| Other Current Liabilities | 264,902 | -22,909 | 241,993 | 31,371 | 273,364 | 111,094 | 384,458 | -404,848 | -20,390 | |
| Net Working Capital | 72,474 | 7,211 | 79,685 | 13,139 | 92,824 | -44,343 | 48,481 | -64,097 | -15,616 | |
| Interest Expense | 20,768 | -1,487 | 19,281 | -1,942 | 17,339 | -1,752 | 15,587 | -33,981 | -18,394 | |
| Net non Operating Income Other | 4 | 1 | 5 | 6 | 11 | 1,016 | 1,027 | -21,784 | -20,757 | |
| Net Debt | 670,972 | -38,782 | 632,190 | -34,221 | 597,969 | -62,482 | 535,487 | -798,094 | -262,607 | |
| Common Stock Shares Outstanding | 33,674 | 328 | 34,002 | 569 | 34,570 | -988 | 33,582 | -33,583 | -1 | |
| Income before Tax | 7,262 | 8,212 | 15,474 | -4,483 | 10,991 | -1,954 | 9,037 | -47,913 | -38,876 | |
| Net Income | 6,958 | 8,704 | 15,662 | 57,181 | 72,843 | -64,797 | 8,046 | -33,080 | -25,034 | |
| Gross Profit | 44,292 | 11,306 | 55,598 | -5,359 | 50,239 | -4,126 | 46,113 | -47,446 | -1,333 | |
| EBIT | 14,999 | 6,196 | 21,195 | -4,783 | 16,412 | -2,260 | 14,152 | -48,271 | -34,119 | |
| EBITDA | 32,075 | 6,354 | 38,429 | -4,797 | 33,632 | -2,236 | 31,396 | -48,296 | -16,900 | |
| Operating Income | 14,996 | 6,196 | 21,192 | -4,783 | 16,409 | -2,260 | 14,149 | -48,271 | -34,122 | |
| Net Income from Continuing Operations | 6,958 | 8,704 | 15,662 | 57,181 | 72,843 | -64,797 | 8,046 | -33,080 | -25,034 | |
| Net Income Applicable to Common Shares | 6,958 | 8,704 | 15,662 | 57,181 | 72,843 | -64,797 | 8,046 | -33,080 | -25,034 |
Comments
How you think about this?